Neuralink Corp
7
6
6
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Clinical Outcome Assessment for AT & BCI
Role: collaborator
Precise Robotically IMplanted Brain-Computer InterfacE
Role: lead
VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration
Role: lead
GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices
Role: lead
UAE-PRIME: A Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices
Role: lead
Control of Assistive Devices Via Brain-Computer Interface Technology
Role: lead
CAN-PRIME: Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices
Role: lead
All 7 trials loaded